Response to Letter to the Editor for the Article Entitled “Short and Long-Term Prognostic Significance of Galectin-3 in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention”
Restricted accessLetterFirst published online October, 2023
Response to Letter to the Editor for the Article Entitled “Short and Long-Term Prognostic Significance of Galectin-3 in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention”
SunYWangCSRenJ. Galectin-3 as a novel biomarker of cardiovascular disease. Angiology. 2023;74:900-901.
2.
KöktürkUPüşüroğluHSomuncuMU, et al.Short and long-term prognostic significance of galectin-3 in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2023;74:889-896.
3.
TousoulisDAntoniadesCKoumallosNStefanadisC. Proinflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev. 2006;17: 225-233.
4.
LiuFTRabinovichGA. Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci. 2010;1183:158-182.
5.
FalconeCLucibelloSMazzucchelliI, et al.Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome. Int J Immunopathol Pharmacol. 2011; 24:905-913.
